secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2022-08-09T23:59:59+00:00
Accession:  0001779128-22-000081
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade Q2 revenue up 175% to $35.6M; net income $8.4M vs loss year ago
---------------------------------------------------------------------

- Total revenue $35.6M, up 175% YoY; MediMobility revenue $17.2M (+1,013%) driven by Trinity acquisition.
- Short Distance revenue $11.0M (+89%) on Helijet acquisition and higher pricing; Flight Margin 14.3% vs 23.0% YoY.
- Net income $8.4M vs net loss $24.3M year ago; adjusted EBITDA loss $(6.1)M vs $(2.6)M.
- Europe acquisitions of three urban air mobility operators expected to close late Summer 2022.
- JetBlue partnership launched June 23; Blade Airport service run-rate above pre-pandemic levels.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912822000081/0001779128-22-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912822000081/blde-20220809.htm
  HTML page:      https://secwatch.observer/filing/0001779128-22-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer